A new working paper provides a practical guide on immunization costing primary data collection and analysis. We would like to invite the Immunization Economics community to explore the working paper and provide feedback

Did you know that the models developed by the DOVE project estimate the costs averted by vaccination? The models focuses on ten antigens and 94 low- and middle-income countries, 2001-2030. Results are used at the global and regional level to advocate for new vaccine introduction and increased coverage.

We identified these 10 articles related to the economics of immunization. These articles were gathered from the START Center Vaccine Delivery Research Digest resource — up to the latest issue in January 2019

Immunization spending data play a key role in informing policy and planning. In this recently published webinar video, panel of experts discuss how countries can better produce, analyze, and present immunization spending data.

The Immunization Costing Action Network (ICAN) will develop methodological guidance and a customizable costing tool to support the costing of immunization campaigns. They will also conduct 3 campaign costing studies this year. You are invited to provide input.

New video features the Immunization Costing Action Network (ICAN). The ICAN bridges critical gap in immunization economics policymaking and implementation through their country work and cost catalogue

In this Learning Network for Countries in Transition (LNCT) blog, R4D’s Helen Saxenian, Leah Ewald, and Meghan O’Connell and Logan Brenzel from the Gates Foundation outline 4 things ministers of finance need to know about immunization in Gavi transitioning countries

New research looking into the extra dividends of vaccination will formally quantify the broad benefits of measles vaccination on childhood health,and the long-term labor-market gains.

A recent commentary by the DOVE project explored the economic burden of pneumonia, diarrhea, and measles for households in Uganda. This is the first-ever study of such kind in Uganda, and policy makers are taking notice

The Immunization Resource Tracking Project at Abt Associates has developed resources to promote the production and use of immunization expenditure data - from policy briefs and a policy primer, to a podcast and webinar.

New podcast focused on ensuring adequate resources for immunization services, includes tips and tools for immunization program managers. Hear from global experts on why spending data is becoming more important for immunization programs

Upcoming March meeting in Washington D.C. will highlight the results of the benefit-cost analysis reference case guidance project, applicable to immunization and other policies in low- and middle-income countries. Dean Jamison plenary speaker.

Promising immunizations for diseases that affect mostly people in low- and middle-income countries need help getting to market, urge David C. Kaslow and colleagues.

A new special issue of PNAS focuses on the role of vaccination in fighting antimicrobial resistance.

 Public health researchers discuss the importance of making economic evaluations of vaccines AMR-sensitive, outline how this can be done, and offer a roadmap for future research. read more here

Following a call for concept notes last year, the VoVRN Secretariat, members of the Steering Committee, and external expert reviewers identified promising studies to recommend for funding. Learn more about these projects here

An overview of the global policies, potential interventions and strategies related to the integration of immunization services - with guidance and country examples. Read here.

Although vaccines continue to protect millions against debilitating, life-threatening diseases; new WHO report starkly illustrates how easily hard-won gains are lost.. Read key messages or download full report.

Pneumonia, Diarrhea, and Measles force Bangladeshi households to make difficult financial decisions when illnesses arise. The Decade of Vaccine Economics study continues to shed light on the importance of preventing common childhood illness. Read more here

Use of behaviorally informed interventions to increase vaccination uptake: a portfolio of results from the General Service Administration's Office of Evaluation Sciences. Read more here

Focusing on the Costing of Immunization Programs, application for TVEE workshop in Jaipur will open until Nov 22nd. Recent workshops in India and Uganda covers multiple topics and utilized in-class lectures supported by case-studies and exercises. Read more here

The ICAN team hosted a webinar in October: “How to Use the Immunization Delivery Cost Catalogue (IDCC): Presentation and Q&A session.” Access presentation and recording here

The ICAN team presented a poster on the Immunization Delivery Cost Catalogue (IDCC) at the recent 5th Global Symposium on Health Systems Research (HSR2018) in Liverpool, United Kingdom. see poster here

An analysis of Mozambique’s 2015 immunization spending reveals that despite adequate resources and increases in immunization coverage, challenges to the immunization program persist. Read more here

Abt’s study on the role of the private sector in immunization in Benin, Georgia and Malawi reveals that governments’ ability to regulate private sector services and promote quality and affordable services remains a challenge. Read more here

Registration has now opened for BactiVac 2nd Annual Network Meeting. The event will be held on 20 & 21 March 2019 in Birmingham, UK. Read more here

WHO-Geneva office is recruiting a Health Economist for the Supply Technology and Financing Team in EPI. This position will lead immunization financing work within the IVB department. Apply by Oct 29, 2018. See more here

This position manages the research projects in the portfolio of Professor David E. Bloom, including the Value of Vaccination Research Network (VoVRN) project, a multi-year effort to fund and encourage new research on the social and economic benefits of vaccination. Learn more about job opening here

ThinkWell’s Immunization Costing Action Network (ICAN) has launched a refresh of the most comprehensive, current, and standardized global evidence on the cost of vaccine delivery on the Immunization Economics platform. See more here